首页> 美国卫生研究院文献>Journal of Cardiology Cases >Pathological evaluation 18 years after bare-metal stent implantation in the superficial femoral artery
【2h】

Pathological evaluation 18 years after bare-metal stent implantation in the superficial femoral artery

机译:浅谈后18年的裸金属支架植入浅表股动脉18年

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Bare-metal stents (BMSs) have been generally applied for the treatment of peripheral artery disease in patients with femoropopliteal disease. However, very long-term pathological findings after BMS implantation have not been elucidated to date. We experienced an autopsy case in which we performed a pathological evaluation 18 years after BMS implantation in the right superficial femoral artery. The BMS was totally occluded and filled with remarkable neointima formation. Neointima was mainly composed of a lot of rather atrophic smooth muscles and intercellular spaces containing dense collagenous fibers. Furthermore, regional fatty infiltration was also observed, but inflammatory cell infiltration, such as macrophages and lymphocytes, was not recognized obviously even around the struts. Judging from the pathological findings, the main mechanism of the very long-term in-stent restenosis in the patients with femoropopliteal disease was continuous proliferation of smooth muscle cells that led to the totally occlusive disease. This observation leads us to speculate that continuous elution of an anti-proliferating drug over a longer duration, at least beyond 1 year, would be effective to prevent chronic-phase restenosis. Further development of devices that can be used in the femoropopliteal artery is needed in light of this speculation.
机译:晶体支架(BMS)通常用于治疗股骨展性疾病患者的外周血动脉疾病。然而,在BMS植入后迄今未阐明的BMS植入后的非常长期的病理结果。我们体验了一种尸检案例,在右侧股动脉均为BMS植入后18年进行病理评估。 BMS完全封闭并充满了非凡的新内膜形成。内部主要由许多相当萎缩的平滑肌和含有致密胶原纤维的细胞间隙组成。此外,还观察到区域脂肪渗透,但甚至在支柱周围没有显着识别炎症细胞浸润,例如巨噬细胞和淋巴细胞。从病理学发现中判断,股骨质上疾病患者的长期内骨折的主要机制是平滑肌细胞的连续增殖,导致完全闭塞的疾病。这种观察结果导致我们推测,在更长的时间内连续洗脱抗增殖药物,至少超过1年,可有效预防慢性相再狭窄。鉴于这种猜测,需要进一步开发可用于股骨造质动脉的装置。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号